Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
One approach that is showing promise in improving treatment options for ovarian cancer, is immunotherapy. This approach spurs the patient's own ...
However, if a new generation of immunotherapy drugs called checkpoint inhibitors were used in these hyper-mutated tumors, perhaps more cancer ...
Both Keytruda and Yervoy are part of a class of cancer immunotherapy drugs (Keytruda is a PD-1 inhibitor and Yervoy is a CTLA-4 antibody).
Cancer immunotherapy takes centre stage in a series of articles about harnessing the immune system for therapy published March 25 as a special ...
“Researchers have dreamed of turning the immune system against tumors ... Patients with breast cancer have thus had limited access to the kinds of ...
Rather than inhibiting cellular signals that arise from a cancer-driving ... terms of signalling strength become full-fledged players in the immune system.
More than 80 percent of local cancer patients regularly take dietary ... said they take nutritional supplements to strengthen their immune system, while ...
The NY-ESO-1 protein is provided by the Ludwig Institute for Cancer ... in vivo approaches to enable the body's immune system to fight disease.
To measure the drug delivery process in pancreatic cancer through fluorescence imaging, special expertise and equipment is needed. In this study ...
“A lot of cancers have seen improvement. Pancreatic cancer has not. So it remains a significant challenge,” says Dr. Tanios Bekaii-Saab, an oncologist ...
Researchers looking a t the causes of liver cancer say they've narrowed ... Obesity is also linked to breast cancer, pancreatic cancer, ovarian cancer ...
Specifically, the research shows that the combination of AR-42 and cisplatin synergistically kills bladder cancer cells through apoptosis and influences ...
INTRODUCTION: The aim of the study was to assess the waiting time, from establishing the indications for radical cystectomy to surgery, in patients ...
In the 1970s, researchers and scientists discovered the association between artificial sweeteners and bladder cancer in laboratory rats. Since then ...
Cold Genesys is advancing to Phase III trials for its adenovirus-mediated oncolytic gene therapy targeting invasive bladder cancer. Similar to T-Vec, ...
Bladder cancer is the most common malignancy of the urinary tract. Carcinoma in situ (CIS) is an aggressive form of the tumour located at the surface ...
RSC Publishing - Royal Society of Chemistry
Bladder cancer is one of the most prevalent malignancies of the genitourinary tract, and approximately 25% of patients with superficial cancers ...
“In a real-world population, adjuvant chemotherapy provided a survival benefit in patients with locally advanced bladder cancer who had not been ...
Minimally Invasive Resection of Early Lung Cancers
For patients with very small-sized lung tumors and indolent lesions, cancer-free survival may not necessarily be compromised by undergoing less invasive approaches that intentionally resect less lung tissue, such as sublobar resections. This review looks at the current data and guidelines for thoracoscopic resection of stage I NSCLC and discusses the potential for limited lung resection in patients with the disease.
For patients with very small-sized lung tumors and indolent lesions, cancer-free survival may not necessarily be compromised by undergoing less invasive approaches that intentionally resect less lung tissue, such as sublobar resections. This review looks at the current data and guidelines for thoracoscopic resection of stage I NSCLC and discusses the potential for limited lung resection in patients with the disease.
Smaller Incisions for Smaller Cancers
As we move forward into the promising future of early detection for lung cancer and the prospect of making strides in survival and cure, thoracic surgeons will continue to be called upon to innovate and to determine, for each patient, the surgical approach that will be most effective and have the fewest comorbidities. Smaller early-stage tumors may lend themselves to less radical lung parenchymal sparing resections or no surgery at all.
As we move forward into the promising future of early detection for lung cancer and the prospect of making strides in survival and cure, thoracic surgeons will continue to be called upon to innovate and to determine, for each patient, the surgical approach that will be most effective and have the fewest comorbidities. Smaller early-stage tumors may lend themselves to less radical lung parenchymal sparing resections or no surgery at all.
Shared Decision Making and Screening: An Ongoing Dialogue Informed by Data
With the routine capturing of data about all aspects of the management of patients who undergo screening, the opportunity exists to create prospective registries designed to more completely capture relevant prognostic information that will be able to inform future discussions about the optimal surgical intervention.
With the routine capturing of data about all aspects of the management of patients who undergo screening, the opportunity exists to create prospective registries designed to more completely capture relevant prognostic information that will be able to inform future discussions about the optimal surgical intervention.
Science Daily Cancer News
A new study of women with early-stage breast cancer finds that surgeons no longer universally remove most of the lymph nodes in the underarm area when a biopsy of the nearby lymph nodes shows cancer -- a major change in breast cancer management.
A protein has been found that is critical to both the normal development of the brain and, in many cases, the development of medulloblastoma, a fast-growing brain tumor that usually strikes children under 10. When the researchers cut the level of the protein Eya1 in half in mice prone to develop medulloblastoma, the animals' risk of dying from the disease dropped dramatically.
Men with a high fitness level in midlife appear to be at lower risk for lung and colorectal cancer, but not prostate cancer, and that higher fitness level also may put them at lower risk of death if they are diagnosed with cancer when they're older, according to a study.
Scientists have found a new way to make chemotherapy more effective against breast cancer cells. They show that blocking a cellular quality control mechanism before administering chemotherapy makes breast cancer cells die faster than when they were exposed to chemotherapy alone. The work is a long way from being applied in people, but it could lead to new treatment strategies for patients in the future.
Doctors strive to make treatment decisions together with their patients – but is the decision really shared? According to researchers, shared decision-making isn’t easy, and clinicians need help. The international research group has studied the decision aids for treatment choice of localized prostate cancer.
Researchers effectively, safely overcome radiation resistance in leukemia with an engineered precision medicine
Improved survival rates have been demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients, according to a new study.
Tambahkan Komentar